High Tower Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Call Options Transaction History

High Tower Advisors, LLC

$68.3 Billion
Q3 2024

Call Options

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2024 May 06, 2024	BUY	$87.05 - $102.89 $17,410 - $20,578	200 New	200 $18,000
Q2 2022 Aug 10, 2022	BUY	$62.81 - $96.09 $939,197 - $1.44 Million	14,953 Added 31814.89%	15,000 $84,000
Q1 2022 May 12, 2022	SELL	$81.07 - $115.44 $3.2 Million - $4.55 Million	-39,453 Reduced 99.88%	47 $4,000
Q2 2021 Aug 06, 2021	BUY	$122.48 - $139.69 $4.83 Million - $5.51 Million	39,450 Added 78900.0%	39,500 $97,000
Q4 2020 Feb 10, 2021	SELL	$110.36 - $151.14 $656,642 - $899,282	-5,950 Reduced 99.17%	50 $105,000
Q3 2020 Nov 13, 2020	BUY	$103.87 - $120.36 $311,610 - $361,080	3,000 Added 100.0%	6,000 $25,000
Q3 2017 Nov 14, 2017	SELL	N/A	-3,500 Reduced 53.85%	3,000 $0
Q2 2017 Aug 14, 2017	BUY	N/A	6,500	6,500 $0

Others Institutions Holding XBI

# of Institutions

925

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

Goldman Sachs Group Inc New York, NY

12.7M
Shares

$1.17 Billion
0.21% of portfolio
Jpmorgan Chase & CO New York, NY

12.3M
Shares

$1.13 Billion
0.1% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

9.23M
Shares

$847 Million
2.24% of portfolio
Morgan Stanley New York, NY

8.02M
Shares

$736 Million
0.06% of portfolio
Citigroup Inc

7.75M
Shares

$712 Million
0.45% of portfolio

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.